The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
Open accessAbstract
Primary infection with the human oncogenic Epstein-Barr virus (EBV) can result in infectious mononucleosis (IM), a self-limiting disease caused by massive lymphocyte expansion that predisposes for the development of distinct EBV-associated lymphomas. Why some individuals experience this symptomatic primary EBV infection, whereas the majority acquires the virus asymptomatically, remains unclear. Using a mouse model with reconstituted human immune system components, we show that depletion of human natural killer (NK) cells enhances IM symptoms and promotes EBV-associated tumorigenesis mainly because of a loss of immune control over lytic EBV infection. These data suggest that failure of innate immune control by human NK cells augments symptomatic lytic EBV infection, which drives lymphocyte expansion and predisposes for EBV-associated malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni1009 · Cited by 1,830 · cited 2×
“Activated memory T cells weremainly foundwithin theCD8 T cell compartment in infected animals (Figures S2A andS2B) and expanded at the cost of naive CD8 T cell frequencies with NK cell depletion significantly affecting CX3CR1 upregulation and expansion of CD11a CD127 CD8 T cells, which in mice have been proposed to be…”
BackgroundAdaptive immune features of natural killer cells
Sun, J. C., Beilke, J. N., & Lanier, L. L. (2009) · Nature · doi:10.1038/nature07665 · Cited by 1,619
Imai, K., Matsuyama, S., Miyake, S., Suga, K., & Nakachi, K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03231-1 · Cited by 1,190
(1948) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1948.tb28186.x · Cited by 1,141
Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice
Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J.-C., Lanzavecchia, A., & Manz, M. G. (2004) · Science · doi:10.1126/science.1093933 · Cited by 993
Imprint of human cytomegalovirus infection on the NK cell receptor repertoire
Gumá, M., Angulo, A., Vilches, C., Gómez-Lozano, N., Malats, N., & López-Botet, M. (2004) · Blood · doi:10.1182/blood-2004-05-2058 · Cited by 865
Lopez-Vergès, S., Milush, J. M., Schwartz, B. S., Pando, M. J., Jarjoura, J., York, V. A., Houchins, J. P., Miller, S., Kang, S.-M., Norris, P. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110900108 · Cited by 822
Cellular responses to viral infection in humans: lessons from Epstein–Barr virus
Hislop, A. D., Taylor, G. S., Sauce, D., & Rickinson, A. B. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141553 · Cited by 766
Paust, S., Gill, H. S., Wang, B.-Z., Flynn, M. P., Moseman, E. A., Senman, B., Szczepanik, M., Telenti, A., Askenase, P. W., Compans, R. W., et al. (2010) · Nature Immunology · doi:10.1038/ni.1953 · Cited by 694
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1
Melkus, M. W., Estes, J. D., Padgett-Thomas, A., Gatlin, J., Denton, P. W., Othieno, F. A., Wege, A. K., Haase, A. T., & Garcia, J. V. (2006) · Nature Medicine · doi:10.1038/nm1431 · Cited by 652
Natural killer cells act as rheostats modulating antiviral T cells
Waggoner, S. N., Cornberg, M., Selin, L. K., & Welsh, R. M. (2012) · Nature · doi:10.1038/nature10624 · Cited by 607
Luzuriaga, K., & Sullivan, J. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001116 · Cited by 606
Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.953 · Cited by 579
Self-citationSPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
Kutok, J. L., & Wang, F. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100209 · Cited by 493
Björkström, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., Michaëlsson, J., Malmberg, K.-J., Klingström, J., Ahlm, C., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100762 · Cited by 479
X-Linked Lymphoproliferative Disease
Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H. D., Wolf, H., Bonnefoy, J.-Y., Biassoni, R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.337 · Cited by 477
Self-citationIdentification, activation, and selective in vivo ablation of mouse NK cells via NKp46
Walzer, T., Bléry, M., Chaix, J., Fuseri, N., Chasson, L., Robbins, S. H., Jaeger, S., André, P., Gauthier, L., Daniel, L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609692104 · Cited by 476
Self-citationCharacteristics of Hodgkin's Lymphoma after Infectious Mononucleosis
Hjalgrim, H., Askling, J., Rostgaard, K., Hamilton-Dutoit, S., Frisch, M., Zhang, J.-S., Madsen, M., Rosdahl, N., Konradsen, H. B., Storm, H. H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023141 · Cited by 433
Zhang, Y., Wallace, D. L., De Lara, C. M., Ghattas, H., Asquith, B., Worth, A., Griffin, G. E., Taylor, G. P., Tough, D. F., Beverley, P. C. L., et al. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02573.x · Cited by 376
Shultz, L. D., Saito, Y., Najima, Y., Tanaka, S., Ochi, T., Tomizawa, M., Doi, T., Sone, A., Suzuki, N., Fujiwara, H., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000475107 · Cited by 366
Balfour, H. H., Odumade, O. A., Schmeling, D. O., Mullan, B. D., Ed, J. A., Knight, J. A., Vezina, H. E., Thomas, W., & Hogquist, K. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis646 · Cited by 337
Lang, P. A., Lang, K. S., Xu, H. C., Grusdat, M., Parish, I. A., Recher, M., Elford, A. R., Dhanji, S., Shaabani, N., Tran, C. W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118834109 · Cited by 311
Strowig, T., Gurer, C., Ploss, A., Liu, Y.-F., Arrey, F., Sashihara, J., Koo, G., Rice, C. M., Young, J. W., Chadburn, A., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081720 · Cited by 300
Self-citationPetitdemange, C., Becquart, P., Wauquier, N., Béziat, V., Debré, P., Leroy, E. M., & Vieillard, V. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002268 · Cited by 270
Epstein-Barr Virus Lytic Infection Contributes to Lymphoproliferative Disease in a SCID Mouse Model
Hong, G. K., Gulley, M. L., Feng, W.-H., Delecluse, H.-J., Holley-Guthrie, E., & Kenney, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13993-14003.2005 · Cited by 225
Self-citationThe immune response to primary EBV infection: a role for natural killer cells
Williams, H., McAulay, K., Macsween, K. F., Gallacher, N. J., Higgins, C. D., Harrison, N., Swerdlow, A. J., & Crawford, D. H. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05452.x · Cited by 197
Yajima, M., Imadome, K., Nakagawa, A., Watanabe, S., Terashima, K., Nakamura, H., Ito, M., Shimizu, N., Honda, M., Yamamoto, N., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590502 · Cited by 183
Pappworth, I. Y., Wang, E. C., & Rowe, M. (2007) · Journal of Virology · doi:10.1128/jvi.01777-06 · Cited by 178
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors
White, R. E., Rämer, P. C., Naresh, K. N., Meixlsperger, S., Pinaud, L., Rooney, C., Savoldo, B., Coutinho, R., Bödör, C., Gribben, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58092 · Cited by 166
Self-citationHorowitz, A., Newman, K. C., Evans, J. H., Korbel, D. S., Davis, D. M., & Riley, E. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000106 · Cited by 134
Eidenschenk, C., Dunne, J., Jouanguy, E., Fourlinnie, C., Gineau, L., Bacq, D., McMahon, C., Smith, O. P., Casanova, J., Abel, L., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503269 · Cited by 124
Strowig, T., Chijioke, O., Carrega, P., Arrey, F., Meixlsperger, S., Rämer, P. C., Ferlazzo, G., & Münz, C. (2010) · Blood · doi:10.1182/blood-2010-02-270678 · Cited by 116
Self-citationBihl, F., Pecheur, J., Bréart, B., Poupon, G., Cazareth, J., Julia, V., Glaichenhaus, N., & Braud, V. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001486 · Cited by 93
T Cell–Mediated Control of Epstein‐Barr Virus Infection in Humanized Mice
Yajima, M., Imadome, K., Nakagawa, A., Watanabe, S., Terashima, K., Nakamura, H., Ito, M., Shimizu, N., Yamamoto, N., & Fujiwara, S. (2009) · The Journal of Infectious Diseases · doi:10.1086/644644 · Cited by 83
Dynamics of Epstein‐Barr virus DNA levels in serum during EBV‐associated disease
Berger, C. T., Day, P. J., Meier, G., Zingg, W., Bossart, W., & Nadal, D. (2001) · Journal of Medical Virology · doi:10.1002/jmv.1078 · Cited by 83
Self-citationPrimary Epstein-Barr virus infection does not erode preexisting CD8+ T cell memory in humans
Odumade, O. A., Knight, J. A., Schmeling, D. O., Masopust, D., Balfour, H. H., & Hogquist, K. A. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112401 · Cited by 78
HIV Infection Is Associated with a Preferential Decline in Less-Differentiated CD56dimCD16+NK Cells
Hong, H. S., Eberhard, J. M., Keudel, P., Bollmann, B. A., Ballmaier, M., Bhatnagar, N., Zielinska‐Skowronek, M., Schmidt, R. E., & Meyer‐Olson, D. (2009) · Journal of Virology · doi:10.1128/jvi.01675-09 · Cited by 74
Sashihara, J., Hoshino, Y., Bowman, J. J., Krogmann, T. A., Burbelo, P. D., Coffield, V. M., Kamrud, K. I., & Cohen, J. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002308 · Cited by 51
Mice with human immune system components as in vivo models for infections with human pathogens
Rämer, P. C., Chijioke, O., Meixlsperger, S., Leung, C. S. K., & Münz, C. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.151 · Cited by 51
Self-citationCD8+ T cell immunity to Epstein-Barr virus and Kaposi’s sarcoma-associated herpes virus
Hislop, A. D., & Sabbah, S. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.10.005 · Cited by 25
Cited by
The Immunology of Epstein-Barr Virus–Induced Disease
Taylor, G. S., Long, H. M., Brooks, J. M., Rickinson, A. B., & Hislop, A. D. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112326 · Cited by 602
Humanized Mouse Models of Clinical Disease
Walsh, N. C., Kenney, L. L., Jangalwe, S., Aryee, K.-E., Greiner, D. L., Brehm, M. A., & Shultz, L. D. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100332 · Cited by 562
Primary Epstein-Barr virus infection
Dunmire, S. K., Verghese, P. S., & Balfour, H. H. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.03.001 · Cited by 520
Epstein–Barr virus and multiple sclerosis
Soldan, S. S., & Lieberman, P. M. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00770-5 · Cited by 467
IL-10: A Multifunctional Cytokine in Viral Infections
Rojas, J. M., Avia, M., Martín, V., & Sevilla, N. (2017) · Journal of Immunology Research · doi:10.1155/2017/6104054 · Cited by 408
Metadata
- Authors
- Chijioke, O., Müller, A., Feederle, R., Barros, M. H. M., Krieg, C., Emmel, V., Marcenaro, E., Leung, C. S., Antsiferova, O., Landtwing, V., Bossart, W., Moretta, A., Hassan, R., Boyman, O., Niedobitek, G., Delecluse, H.-J., Capaul, R., & Münz, C.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 5
- Issue
- 6
- Pages
- 1489-1498
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2102364227
- Cited by
- 258
- References
- 41
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.